Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-14-074864
Filing Date
2014-12-18
Accepted
2014-12-18 21:44:39
Documents
1
Period of Report
2014-12-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v397070_4.html 4  
1 OWNERSHIP DOCUMENT v397070_4.xml 4 4260
  Complete submission text file 0001144204-14-074864.txt   5883
Mailing Address 787 SEVENTH AVENUE NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE NEW YORK NY 10019 (212) 554-4484
TG THERAPEUTICS, INC. (Issuer) CIK: 0001001316 (see all company filings)

EIN.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 750 LEXINGTON AVE NEW YORK NY 10022
Business Address
WEISS MICHAEL S (Reporting) CIK: 0001038977 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32639 | Film No.: 141297529